Articles Archives - Page 121 of 714

WednesdayNov 29, 2023 9:00 am

Webcast Sheds Light on Diamond Lake Minerals Inc. (DLMI) Groundbreaking STO Strategy Amid Rapid Early Buildup

Diamond Lake Minerals is a Utah-based leader in the digital asset and security token space, focused on building and distributing wealth through a smart model that combines holding multiple subsidiaries with targeted STOs (Security Token Offerings) A principal element of DLMI’s strategy is to attract traditional investors familiar with buying stock but generally digital asset-avoidant because of their unfamiliarity with new tech alternatives DLMI’s subsidiary holdings are based upon building a vertically integrated company that develops enterprises to the point they can become self-sufficient and can eventually be spun off into their own IPOs Under the company’s new and growing…

TuesdayNov 28, 2023 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Marks Exceptional Performance for Q3 2023; Eyes Further Potential Margin Expansion

SuperCom, a global leading provider of traditional and digital identity solutions, just reported a 550% growth in EBITDA and a 74% growth in gross profit margin for Q3 2023 Gross profit also saw an 89% YOY growth, and revenue YOY increased to $6.8 million from $6.3 million Ordan Trabelsi, SuperCom’s President and CEO, attributed impressive performance to the company’s successful execution of its growth strategy SuperCom (NASDAQ: SPCB), a global leading provider of traditional and digital identity solutions offering advanced safety, identification, and security solutions to governments, just released its financial and operating results for the third quarter of the…

TuesdayNov 28, 2023 9:00 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Provides Solutions to Help Businesses, Governments, and Individuals, Protect Themselves From Hacking

Sekur signed a major distribution agreement with a distributor in the Hashemite Kingdom of Jordan and The Republic of Iraq to distribute its entire Sekur Swiss-hosted private and encrypted communications platform CEO Alain Ghiai is participating in weekly discussions about cybersecurity and internet security on Fox Business TV’s Weekly Sekur Hack of the Week with multimedia journalist Ana Berry to raise awareness of recent cybersecurity threats Sekur’s 100% owned Swiss-hosted servers offer closed-loop secure encrypted products, including SekurVPN, SekurMail, SekurMessenger, and other services for businesses, governments, and individuals Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0), a cybersecurity and…

MondayNov 27, 2023 10:30 am

SOHM Inc. (SHMN) Is ‘One to Watch’

In August 2023, SOHM signed an LOI with CGA Intellectual Holdings Inc. to acquire disruptive stem cell technology and patents The company announced in July 2023 it had closed on the needed financing for its various ongoing projects SOHM announced in April 2023 it had signed an exclusive distribution agreement for its latest product, the anticonvulsant Levetiracetam The company in March 2023 introduced its new topical skincare line of products SOHM (OTC: SHMN) is a generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” (Global Prosperity). SOHM was founded in 1998 and is headquartered in Chino Hills,…

MondayNov 27, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Third-Quarter Financial Highlights, Voices Support for Expanded National Quantum Initiative

D-Wave third-quarter revenue grew by 51% year-over-year D-Wave’s third quarter bookings increased by 53% year-over-year, representing the company’s sixth consecutive quarter of year-over-year booking growth, while the first three quarters bookings increased by 125% when compared to the year earlier period CEO Dr. Alan Baratz recently met with Members of Congress to urge them to support the reauthorization of the National Quantum Initiative and ensure that it was expanded to encompass all quantum computing technologies D-Wave Quantum (NYSE: QBTS), a leader in commercial quantum computing systems, software, and services, recently announced financial results for its fiscal third quarter, which ended…

MondayNov 27, 2023 9:00 am

Software Effective Solutions Corp. (SFWJ) Is ‘One to Watch’

MedCana announced in May 2023 full-scale production of non-THC cannabis for export to Europe The company earlier in 2023 commenced construction of crop production infrastructure at sites in Central and South America MedCana has engaged in talks with the government of Argentina about starting production in that country The company in 2023 acquired the assets of Tokan Corp., including an ERP software platform for the cannabis industry Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company…

WednesdayNov 22, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer

Genprex was granted orphan drug designation by the FDA earlier this year for development of REQORSA combined with Tecentriq in small cell lung cancer Use of REQORSA combined with Tecentriq is the subject of Genprex’s upcoming Acclaim-3 clinical trial Genprex took part in two events in October – the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; and Genprex’s own hosted event, a Virtual Key Opinion Leaders on Bringing Gene Therapy to the Fight Against Lung Cancers Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes, was…

WednesdayNov 22, 2023 9:00 am

Clene Inc. (NASDAQ: CLNN) Capitalizing on the Promising Chemical and Therapeutic Properties of Nanocrystals to Address High Unmet Medical Needs

Clene is focused on developing and commercializing novel clean-surfaced nanotechnology (“CSN(R)”) therapeutics The company utilizes an electro-crystallization nanotherapeutics platform, which results in nanocrystals that exhibit catalytic activities multiple times higher than numerous other commercially available nanoparticles that the company has comparatively evaluated Clene is focusing on central nervous system (“CNS”) disorders like amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease (“PD”) Its lead investigational product, CNM-Au8(R), has so far demonstrated a good safety and tolerability profile, with Phase 2 trials suggesting efficacy in ALS patients Nanotechnology has attracted a great deal of the scientific community’s attention thanks to…

TuesdayNov 21, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Makes Visionary Pitch for Domestic REE Supply Chain at Fall Mining Showcase 2023

Rare earth element (“REE”) enterprise Ucore Rare Metals Inc. is developing an innovative separation technology for REEs critical to modern computer technologies The company is preparing to advance the operational machinery being used to demonstrate Ucore’s proprietary RapidSX(TM) solution side-by-side with conventional separation technology, designing a similar commercial operation that will begin commissioning next year in Louisiana China currently dominates the global market for mining, processing, and product creation for REEs, leading to American concerns about vulnerability to price and supply policies controlled by China’s government Ucore has received a $4 million award from the U.S. Department of Defense to…

TuesdayNov 21, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) Encouraged by Positive Results from Phase 2a Trial in Patients with Mild AD; Explores Paths Forward for the Development of Lomecel-B(TM)

Longeveron recently released topline results from its Phase 2a trial evaluating Lomecel-B(TM) as a potential treatment for mild AD The study met its primary safety endpoint across all four study groups and showed positive and statistically significant results in secondary endpoint involving the Composite Alzheimer’s Disease Score (“CADS”) for Lomecel-B(TM) and components of the CADS The positive results are expected to form the basis for further development of Lomecel-B(TM) as a potential treatment for mild AD Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions for which there is an unmet medical need, announced…

Site Search

Company Search

Category: Articles